Sleep bruxism, awake bruxism and headache in children and adolescents: a scoping review.

A scoping review was carried out with the aim of mapping the existing literature on the association between sleep/awake bruxism and primary headache (migraine and tension headache) in children and adolescents. This scoping review followed the method proposed by Arksey & O'Malley and the Joanna Briggs Institute Manual for Evidence Synthesis and was reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses-Extension for Scoping Reviews (PRISMA-ScR). The methods were registered in the Open Science Framework ( View Article and Find Full Text PDF

Removal of the Active Pharmaceutical Substance Entecavir from Water via the Fenton Reaction or Action by the Cyanobacterium .

Entecavir (ETV) is an antiviral used to treat chronic infection caused by the hepatitis B virus, which affects approximately 250 million people worldwide. In order to mitigate the impacts of ETV on the environment, including potential harm to human health, this study evaluated the use of the Fenton-like reaction, which uses iron complexed with ethylenediaminetetraacetic acid (EDTA) at neutral pH, and the microbiological action of in removing ETV from the aqueous medium. Aqueous concentrations of 100 mg/L were subjected to Fenton-like degradation.

Preparation of -Myrcene-Chitosan Nanoparticles and Their Uptake and Toxicity in Larvae.

Mosquito control still relies heavily on synthetic molecules, which can lead to the selection of resistant populations and undesirable environmental problems. This study described the preparation of a nanoparticle of the plant-derived molecule, -myrcene, with chitosan, and the assessment of its toxicity against larvae of the yellow fever mosquito, . By producing fluorescent chitosan nanoparticles, we were able to observe their distribution in the digestive tract of larvae of .

Non-adherence, discontinuation, and seroconversion among people on daily HIV pre-exposure prophylaxis (PrEP) in Brazil: a nationwide cohort study.

The goal of this study was to evaluate characteristics associated with Pre-exposure Prophylaxis for HIV infection (PrEP) non-adherence or discontinuation in Brazil and assess the association between these outcomes and HIV seroconversion. We used linked national dispensing and pathology data to identify people aged 14+ years initiating PrEP in 2018. We estimated non-adherence using the proportion of days covered (PDC), defining non-adherence as PDC < 60%.

Correction: A multi-stage process to develop quality indicators for community-based palliative care using interRAI data.

[This corrects the article DOI: 10.1371/journal.pone.